Psoriasis
Article
Etanercept Improves Psoriatic Arthritis Patient-Reported Outcomes: Results From EDUCATE
Experience Diagnosing, Understanding Care, and Treatment With Etanercept (EDUCATE) is a multicenter, phase 4, 24-week, open-label study of the...
Article
Lifestyle Issues and Psoriasis [editorial]
No abstract available.
Clinical Topics & News
Alefacept in the Treatment of Recalcitrant Palmoplantar and Erythrodermic Psoriasis
Alefacept is the first biologic agent approved by the US Food and Drug Administration for moderate to severe chronic plaque psoriasis. Prior...
Clinical Topics & News
Cyclopamine: Inhibiting Hedgehog in the Treatment of Psoriasis
The steroidal alkaloid cyclopamine, a direct inhibitor of the hedgehog (Hh) intracellular signaling pathway, has demonstrated promising initial...
Clinical Topics & News
Sequential Use of Infliximab and Etanercept in Generalized Pustular Psoriasis
Generalized pustular psoriasis is a dramatic potentially life-threatening psoriasis variant and represents a major therapeutic challenge. Tumor...
Article
Nonlaser UVB-Targeted Phototherapy Treatment of Psoriasis
Nonlaser localized narrowband (290–315 nm) UVB phototherapy was tested in 10 subjects with localized psoriasis. Treatments were given 2 to 3 times...
Clinical Topics & News
Psoriasis Guttata With Palmoplantar Involvement Clinically Mimicking Secondary Syphilis
Papulosquamous eruptions involving the palms and soles are thought to be particularly suggestive of secondary syphilis. Alternative diagnoses...
Article
Perspectives on Psoriasis [editorial]
No abstract available.
Article
Infantile Psoriasis
Psoriasis is a common inherited papulosquamous dermatosis that may be a diagnostic dilemma, particularly in infants and children.
Clinical Topics & News
Partial Remission of Psoriasis Following Rituximab Therapy for Non-Hodgkin Lymphoma
Rituximab, a human-mouse, chimeric, monoclonal antibody that targets the B-cell CD20 antigen and causes rapid and specific B-cell depletion, is...